Humanized Anti-CD20 Antibody, Veltuzumab, in Refractory/Recurrent Non-Hodgkin's Lymphoma: Phase I/II Results

标题
Humanized Anti-CD20 Antibody, Veltuzumab, in Refractory/Recurrent Non-Hodgkin's Lymphoma: Phase I/II Results
作者
关键词
-
出版物
JOURNAL OF CLINICAL ONCOLOGY
Volume 27, Issue 20, Pages 3346-3353
出版商
American Society of Clinical Oncology (ASCO)
发表日期
2009-05-19
DOI
10.1200/jco.2008.19.9117

向作者/读者发起求助以获取更多资源

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now